Juliana H. Halbach, John M. Cala, Samuel Y. Paik & David M. Zalk. (2023) Control Banding and the Global Rise of Qualitative Risk Assessment Strategies. Current Environmental Health Reports.
Crossref
David G. Dolan, Joel P. Bercu, Jessica C. Graham & Ester L. Barle. 2003. Patty's Toxicology. Patty's Toxicology
1
39
.
Yonggang Chen, Luca Iuzzolino, Samantha A. Burgess, Cheol K. Chung, James Corry, Morgan Crawford, Richard Desmond, Erik Guetschow, Clara Hartmanshenn, Nadine Kuhl, Zhu Liu, Hanlin Luo, Alison C. McQuilken, Justin A. Newman, Hong Ren, David A. Thaisrivongs, Zhixun Wang & Eric Sirota. (2023) Leveraging Synergistic Solubility in the Development of a Direct Isolation Process for Nemtabrutinib. Organic Process Research & Development 27:4, pages 659-668.
Crossref
Kirandeep Kaur, Arun B. Prasad, Chou-Yi Hsu, Joseph Oduor Odongo, Satyam Sharma, Yathrib Ajaj, Irfan Rashid Sofi & Zahid Nabi. 2023. Modern Nanotechnology. Modern Nanotechnology
429
453
.
Varun Ahuja & Mohan Krishnappa. (2021) Approaches for setting occupational exposure limits in the pharmaceutical industry. Journal of Applied Toxicology 42:1, pages 154-167.
Crossref
Saemi Shin & Sang-Hoon Byeon. (2021) Review and Improvement of Chemical Hazard Risk Management of Korean Occupational Safety and Health Agency. International Journal of Environmental Research and Public Health 18:17, pages 9395.
Crossref
Saikishore Meruva, Prajwal Thool, Yuchuan Gong, Anjali Agrawal, Shyam Karki, William Bowen, Biplob Mitra & Sumit Kumar. (2021) A Novel Use of Nanocrystalline Suspensions to Develop Sub-Microgram Dose Micro-Tablets. Journal of Pharmaceutical Sciences 110:9, pages 3276-3288.
Crossref
David M. Zalk, Elaine West & Deborah I. Nelson. 2001. Patty's Industrial Hygiene. Patty's Industrial Hygiene
1
37
.
Barbara J. Dawson, Kyle B. Dotson, Faye Grimsley, Thomas Grumbles, Zack Mansdorf, David Roskelley, Jennifer Sahmel, Noel Tresider & Candace Tsai. 2001. Patty's Industrial Hygiene. Patty's Industrial Hygiene
1
16
.
Jessica C. Graham, Jedd Hillegass & Gene Schulze. (2020) Considerations for setting occupational exposure limits for novel pharmaceutical modalities. Regulatory Toxicology and Pharmacology 118, pages 104813.
Crossref
T. S. Zazuliak. (2020) Comparative assessment of hygienic regulations on the permissible concentration of chemical substances in the working zone air in the national and European regulation frameworks. Ukrainian Journal of Occupational Health 2020:3, pages 223-238.
Crossref
F. Boccuni, R. Ferrante, F. Tombolini, P. Pingue, A. Porcari & S. Iavicoli. (2020) Workers’ exposure to nano-objects in R&D laboratories: An integrated risk management and communication approach. Safety Science 129, pages 104793.
Crossref
Huaming Sheng, Dae Kim, Alexander S. Chin, Yuejie Zhao, Yong Liu, Ravi Katwaru, Kevin P. Bateman, Andreas Abend & W. Peter Wuelfing. (2020) Development of an automated and High throughput UHPLC/MS based workflow for cleaning verification of potent compounds in the pharmaceutical manufacturing environment. Journal of Pharmaceutical and Biomedical Analysis 188, pages 113401.
Crossref
David M. Zalk & Paul Swuste. (2020) Barrier Banding: A Concept for Safety Solutions Utilizing Control Banding Principles. ACS Chemical Health & Safety 27:4, pages 219-228.
Crossref
Congxin Huang, Jishuai Ma & Angui Li. 2020. Industrial Ventilation Design Guidebook. Industrial Ventilation Design Guidebook
227
243
.
Andrew Maier, Debra Cherry & Elizabeth Friedman. 2020. Information Resources in Toxicology. Information Resources in Toxicology
443
452
.
Marie Fortin & Marie Capdevielle. 2020. An Introduction to Interdisciplinary Toxicology. An Introduction to Interdisciplinary Toxicology
327
338
.
Bruce D Naumann & Susan F Arnold. (2019) Setting surface wipe limits for skin sensitizers. Toxicology and Industrial Health 35:9, pages 614-625.
Crossref
George Procopiou & Justin Mason-Home. 2019. Cytotoxic Payloads for Antibody – Drug Conjugates. Cytotoxic Payloads for Antibody – Drug Conjugates
439
460
.
Matthew Casey, Jason Hamm, Melanie Miller, Tom Ramsey, Richard Schild, Andrew Stewart & Jean Tom. 2019. Chemical Engineering in the Pharmaceutical Industry. Chemical Engineering in the Pharmaceutical Industry
1011
1036
.
Alan Braem, Jason Sweeney & Jean Tom. 2019. Chemical Engineering in the Pharmaceutical Industry. Chemical Engineering in the Pharmaceutical Industry
971
1000
.
Felice C. Simeone, Magda Blosi, Simona Ortelli & Anna L. Costa. (2019) Assessing occupational risk in designs of production processes of nano-materials. NanoImpact 14, pages 100149.
Crossref
Venugopal Dhananjayan, Beerappa Ravichandran, Somnath Sen & Karunamoorthy Panjakumar. 2019. Nanoarchitectonics in Biomedicine. Nanoarchitectonics in Biomedicine
643
676
.
J. Christopher McWilliams & Mark Guinn. 2018. Early Drug Development. Early Drug Development
11
30
.
Roberta Risoluti & Stefano Materazzi. (2018) MicroNIR/Chemometrics Assessement of Occupational Exposure to Hydroxyurea. Frontiers in Chemistry 6.
Crossref
Anna Pałaszewska-Tkacz, Anna Świdwińska-Gajewska & Sławomir Czerczak. (2018) Cisplatin. Documentation of proposed values of occupational exposure limits (OELs). Podstawy i Metody Oceny Środowiska Pracy 34:1(95), pages 13-52.
Crossref
Kevin H Dunn, Adrienne C Eastlake, Michael Story & Eileen D Kuempel. (2018) Control Banding Tools for Engineered Nanoparticles: What the Practitioner Needs to Know. Annals of Work Exposures and Health 62:3, pages 362-388.
Crossref
Kevin N. Woodward. 2018. Regulatory Toxicology in the European Union. Regulatory Toxicology in the European Union
163
242
.
E.V. Sargent, B.D. Naumann & C.S. Schwartz. 2018. Comprehensive Toxicology. Comprehensive Toxicology
44
63
.
Rainald Forbert & Lothar Gail. 2018. Reinraumtechnik. Reinraumtechnik
693
724
.
Nathan M. Drew, Eileen D. Kuempel, Ying Pei & Feng Yang. (2017) A quantitative framework to group nanoscale and microscale particles by hazard potency to derive occupational exposure limits: Proof of concept evaluation. Regulatory Toxicology and Pharmacology 89, pages 253-267.
Crossref
Brian R. Petuch. 2017. Biological Safety. Biological Safety
585
595
.
E.V. Sargent, B.D. Naumann & C.S. Schwartz. 2017. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Ellen C. Faria, Joel P. Bercu, David G. Dolan, Eric J. Morinello, Alison M. Pecquet, Christopher Seaman, Claudia Sehner & Patricia A. Weideman. (2016) Using default methodologies to derive an acceptable daily exposure (ADE). Regulatory Toxicology and Pharmacology 79, pages S28-S38.
Crossref
Robert G. Sussman, Anthony R. Schatz, Tracy A. Kimmel, Allan Ader, Bruce D. Naumann & Patricia A. Weideman. (2016) Identifying and assessing highly hazardous drugs within quality risk management programs. Regulatory Toxicology and Pharmacology 79, pages S11-S18.
Crossref
Adrienne Eastlake, Ralph Zumwalde & Charles Geraci. (2016) Can control banding be useful for the safe handling of nanomaterials? A systematic review. Journal of Nanoparticle Research 18:6.
Crossref
Ester Lovsin Barle, Gian Christian Winkler, Susanne Glowienke, Azeddine Elhajouji, Jana Nunic & Hans-Joerg Martus. (2016) Setting Occupational Exposure Limits for Genotoxic Substances in the Pharmaceutical Industry. Toxicological Sciences 151:1, pages 2-9.
Crossref
Erwan Cheneval, Marc-Antoine Busque, Claude Ostiguy, Jacques Lavoie, Robert Bourbonnais, France Labrèche, Bouchra Bakhiyi & Joseph Zayed. (2016) Green Jobs: Definition and Method of Appraisal of Chemical and Biological Risks. Annals of Occupational Hygiene 60:3, pages 290-304.
Crossref
David M. Zalk & Samuel Y. Paik. 2016. Assessing Nanoparticle Risks to Human Health. Assessing Nanoparticle Risks to Human Health
121
152
.
Selene Araya, Ester Lovsin-Barle & Susanne Glowienke. (2015) Mutagenicity assessment strategy for pharmaceutical intermediates to aid limit setting for occupational exposure. Regulatory Toxicology and Pharmacology 73:2, pages 515-520.
Crossref
Yvonne Bouwman-Boer, Shi Wai Ng & Sylvie Crauste-Manciet. 2015. Practical Pharmaceutics. Practical Pharmaceutics
551
584
.
Michael Juhnke & Edgar John. (2014) Size Reduction as Integral Element for Development and Manufacturing of Engineered Drug Particles. Chemical Engineering & Technology 37:5, pages 757-764.
Crossref
P. A. Schulte, C. L. Geraci, V. Murashov, E. D. Kuempel, R. D. Zumwalde, V. Castranova, M. D. Hoover, L. Hodson & K. F. Martinez. (2013) Occupational safety and health criteria for responsible development of nanotechnology. Journal of Nanoparticle Research 16:1.
Crossref
Andre E. Nel, Elina Nasser, Hilary Godwin, David Avery, Tina Bahadori, Lynn Bergeson, Elizabeth Beryt, James C. Bonner, Darrell Boverhof, Janet Carter, Vince Castranova, J. R. DeShazo, Saber M. Hussain, Agnes B. Kane, Frederick Klaessig, Eileen Kuempel, Mark Lafranconi, Robert Landsiedel, Timothy Malloy, Mary Beth Miller, Jeffery Morris, Kenneth Moss, Gunter Oberdorster, Kent Pinkerton, Richard C. Pleus, Jo Anne Shatkin, Russell Thomas, Thabet Tolaymat, Amy Wang & Jeffrey Wong. (2013) A Multi-Stakeholder Perspective on the Use of Alternative Test Strategies for Nanomaterial Safety Assessment. ACS Nano 7:8, pages 6422-6433.
Crossref
P A Schulte, C L Geraci, L L Hodson, R D Zumwalde, E D Kuempel, V Murashov, K F Martinez & D S Heidel. (2013) Overview of Risk Management for Engineered Nanomaterials. Journal of Physics: Conference Series 429, pages 012062.
Crossref
Kevin Woodward & Kevin WoodwardK. N Woodward. 2012. Toxicological Effects of Veterinary Medicinal Products in Humans. Toxicological Effects of Veterinary Medicinal Products in Humans
81
116
.
E. D. Kuempel, V. Castranova, C. L. Geraci & P. A. Schulte. (2012) Development of risk-based nanomaterial groups for occupational exposure control. Journal of Nanoparticle Research 14:9.
Crossref
S. Armenta & M. Blanco. (2012) Ion Mobility Spectrometry: A Comprehensive and Versatile Tool for Occupational Pharmaceutical Exposure Assessment. Analytical Chemistry 84:10, pages 4560-4568.
Crossref
M. Riediker, C. Ostiguy, J. Triolet, P. Troisfontaine, D. Vernez, G. Bourdel, N. Thieriet & A. Cadène. (2012) Development of a Control Banding Tool for Nanomaterials. Journal of Nanomaterials 2012, pages 1-8.
Crossref
Gurumurthy Ramachandran, John Howard, Andrew Maynard & Martin Philbert. (2021) Handling Worker and Third-Party Exposures to Nanotherapeutics During Clinical Trials. Journal of Law, Medicine & Ethics 40:4, pages 856-864.
Crossref
Rainald Forbert & Lothar Gail. 2012. Reinraumtechnik. Reinraumtechnik
551
579
.
Styliani Gewrgios Tziaferi, Panayiota Sourtzi, Athina Kalokairinou, Evi Sgourou, Emmanouel Koumoulas & Emmanouel Velonakis. (2011) Risk Assessment of Physical Hazards in Greek Hospitals Combining Staff’s Perception, Experts’ Evaluation and Objective Measurements. Safety and Health at Work 2:3, pages 260-272.
Crossref
Deborah Imel Nelson & David M. Zalk. 2001. Patty's Industrial Hygiene. Patty's Industrial Hygiene
1263
1321
.
Tracy A. Kimmel, Robert G. Sussman, Robert H. Ku, Allan W. Ader, M. Brisson, K. Ashley, J. Lesage & S. W. Dean. (2011) Developing Acceptable Surface Limits for Occupational Exposure to Pharmaceutical Substances. Journal of ASTM International 8:8, pages 103480.
Crossref
. (2010) Evaluation of the COSHH Essentials Model with a Mixture of Organic Chemicals at a Medium-Sized Paint Producer. The Annals of Occupational Hygiene.
Crossref
Patricia E. Mc Donnell, John W. Cherrie, Anne Sleeuwenhoek, Andy Gilles & Marie A. Coggins. (2011) Refinement and validation of an exposure model for the pharmaceutical industry. Journal of Environmental Monitoring 13:3, pages 641.
Crossref
David M. Zalk & Samuel Y. Paik. 2011. Assessing Nanoparticle Risks to Human Health. Assessing Nanoparticle Risks to Human Health
139
166
.
Jason C. Hamm, Melanie M. Miller, Thomas Ramsey, Richard L. Schild, Andrew Stewart & Jean W. Tom. 2010. Chemical Engineering in the Pharmaceutical Industry. Chemical Engineering in the Pharmaceutical Industry
417
436
.
Alan D. Braem, Jason T. Sweeney & Jean W. Tom. 2010. Chemical Engineering in the Pharmaceutical Industry. Chemical Engineering in the Pharmaceutical Industry
379
405
.
Susan Wollowitz. (2010) Managing high-potency active pharmaceutical ingredients-A drug sponsor's guide. Drug Development Research 71:7, pages 420-428.
Crossref
Vince Ammoscato, Rebecca Wickenheiser, John Henderson & Stephen Munk. (2010) State-of-the-art process for the safe synthesis of anticancer drugs. Drug Development Research 71:7, pages 439-444.
Crossref
P. A. Schulte, V. Murashov, R. Zumwalde, E. D. Kuempel & C. L. Geraci. (2010) Occupational exposure limits for nanomaterials: state of the art. Journal of Nanoparticle Research 12:6, pages 1971-1987.
Crossref
Örn Almarsson & Christopher J. Galli. 2010. Early Drug Development. Early Drug Development
205
248
.
E.V. Sargent, B.D. Naumann & C.S. Schwartz. 2010. Comprehensive Toxicology. Comprehensive Toxicology
65
85
.
John Howard & Vladimir Murashov. (2009) National nanotechnology partnership to protect workers. Journal of Nanoparticle Research 11:7, pages 1673-1683.
Crossref
David M. Zalk, Samuel Y. Paik & Paul Swuste. (2009) Evaluating the Control Banding Nanotool: a qualitative risk assessment method for controlling nanoparticle exposures. Journal of Nanoparticle Research 11:7, pages 1685-1704.
Crossref
Vladimir Murashov & John Howard. (2009) Essential features for proactive risk management. Nature Nanotechnology 4:8, pages 467-470.
Crossref
Thomas Fuller. 2009. Handbook of Modern Hospital Safety, Second Edition. Handbook of Modern Hospital Safety, Second Edition
1
25
.
Vladimir Murashov & John Howard. (2009) International standards for risk management in nanotechnology. Nature Nanotechnology 4:4, pages 205-206.
Crossref
Vladimir Murashov. (2009) Occupational exposure to nanomedical applications. WIREs Nanomedicine and Nanobiotechnology 1:2, pages 203-213.
Crossref
J W Cherrie, A T Gillies, A Sleeuwenhoek, M van Tongeren, P McDonnell, M Coggins & S R Bailey. (2009) Modelling exposure to pharmaceutical agents. Journal of Physics: Conference Series 151, pages 012063.
Crossref
Andrew Maier. 2009. Information Resources in Toxicology. Information Resources in Toxicology
335
343
.
Yvonne Bouwman-Boer, Paul Le Brun, Christien Oussoren, Ria Tel & Herman WoerdenbagMirjam Crul & Yvonne Bouwman-Boer. 2009. Recepteerkunde. Recepteerkunde
125
145
.
. (2008) Stoffenmanager Exposure Model: Development of a Quantitative Algorithm. The Annals of Occupational Hygiene.
Crossref
A. Osytek, M. Biesaga, K. Pyrzynska & M. Szewczyńska. (2008) Quantification of some active compounds in air samples at pharmaceutical workplaces by HPLC. Journal of Biochemical and Biophysical Methods 70:6, pages 1283-1286.
Crossref
K.N. Woodward. (2008) Assessment of user safety, exposure and risk to veterinary medicinal products in the European Union. Regulatory Toxicology and Pharmacology 50:1, pages 114-128.
Crossref
Chris D Money, Sylvia Jacobi, Mike G Penman, Carlos Rodriguez, Christ De Rooij & Gauke Veenstra. (2007) The ECETOC approach to targeted risk assessment; lessons and experiences relevant to REACH. Journal of Exposure Science & Environmental Epidemiology 17:S1, pages S67-S71.
Crossref
Vladimir Murashov & John Howard. (2016) Biosafety, Occupational Health and Nanotechnology. Applied Biosafety 12:3, pages 158-167.
Crossref
Kathleen KreissGregory A. DayChristine R. Schuler. (2007) Beryllium: A Modern Industrial Hazard. Annual Review of Public Health 28:1, pages 259-277.
Crossref
. (2006) Identification of Exposure Pathways for Opioid Narcotic Analgesics in Pharmaceutical Production Workers. The Annals of Occupational Hygiene.
Crossref
Andrew D. Maynard & Eileen D. Kuempel. (2005) Airborne Nanostructured Particles and Occupational Health. Journal of Nanoparticle Research 7:6, pages 587-614.
Crossref
David G. Dolan, Bruce D. Naumann, Edward V. Sargent, Andrew Maier & Michael Dourson. (2005) Application of the threshold of toxicological concern concept to pharmaceutical manufacturing operations. Regulatory Toxicology and Pharmacology 43:1, pages 1-9.
Crossref
Allan W. Ader, John P. Farris & Robert H. Ku. (2005) Occupational health categorization and compound handling practice systems—roots, application and future. Chemical Health & Safety 12:4, pages 20-26.
Crossref
Thomas H. Connor, Paul J. M. Sessink, Bruce R. Harrison, Jack R. Pretty, Byron G. Peters, Raul M. Alfaro, Appie Bilos, Gwendolyn Beckmann, Michael R. Bing, Lakisha M. Anderson & Robert DeChristoforo. (2005) Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: Results of three studies. American Journal of Health-System Pharmacy 62:5, pages 475-484.
Crossref
Nadine F.J Van Nimmen, Katrien L.C Poels & Hendrik A.F Veulemans. (2004) Highly sensitive gas chromatographic—mass spectrometric screening method for the determination of picogram levels of fentanyl, sufentanil and alfentanil and their major metabolites in urine of opioid exposed workers. Journal of Chromatography B 804:2, pages 375-387.
Crossref
Lothar Gail & Hans-Peter Hortig. 2004. Reinraumtechnik. Reinraumtechnik
404
426
.
Michael B. Hicks, George X. Zhou, David R. Lieberman, Vincent Antonucci, Zhihong Ge, Yao‐Jun Shi, Mark Cameron & Joseph E. Lynch. (2003) In Situ Moisture Determination of a Cytotoxic Compound During Process Optimization. Journal of Pharmaceutical Sciences 92:3, pages 529-535.
Crossref
Rainald Forbert & Lothar Gail. 2002. Reinraumtechnik. Reinraumtechnik
389
408
.
Dennis J. Paustenbach. 2001. Patty's Industrial Hygiene. Patty's Industrial Hygiene.
Dennis J. Paustenbach. 2001. Patty's Industrial Hygiene. Patty's Industrial Hygiene.
BJARNE W. OLESEN, DOMINGO L. MORENO-BELTRÕN, MARIO GRAU-RIOS, ESKO TÄHTI, RAIMO NIEMELÄ, LARS OLANDER & KIM HAGSTRÖM. 2001. Industrial Ventilation Design Guidebook. Industrial Ventilation Design Guidebook
355
413
.
Raimo I. Niemelä, Jorma Rantanen & Mirja K. Kiilunen. (2006) Target Levels—Tools for Prevention. Risk Analysis 18:6, pages 679-688.
Crossref